Latest News about PFE
Recent news which mentions PFE
What This FDA News Could Mean for Pfizer
February 01, 2022
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
From Benzinga
Could This Be A Potential New Weapon In The Fight Against COVID-19?
February 01, 2022
From Benzinga
Is Viatris a Value Trap?
February 01, 2022
From Motley Fool
After Dropping 40%, Is Novavax a Buy?
February 01, 2022
From Motley Fool
3 Pharmaceutical Stocks With Dividend Yields of 2.9% or Better
February 01, 2022
From Motley Fool
A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Surge; Alphabet Earnings in Focus
February 01, 2022
From Benzinga
Pfizer may seek FDA’s OK for COVID vaccine for kids under 5 as soon as Tuesday: reports
January 31, 2022
From MarketWatch
Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
January 31, 2022
From Benzinga
7 Blue-Chip Stocks to Buy for February
January 31, 2022
From InvestorPlace
Novavax: The Fall of a Covid-19 Vaccine Star
January 31, 2022
From InvestorPlace
Why Pfizer Stock Is Sliding Today
January 31, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
From Benzinga
Why Are Ionis Pharmaceuticals Shares Tanking Today?
January 31, 2022
From Benzinga
How Many Boosters Will It Take? A Global Population Beset By Pandemic Fatigue Wants A More Permanent Solution
January 31, 2022
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
Better Dividend Stock: AbbVie or Pfizer?
January 30, 2022
From Motley Fool
From Motley Fool
Is This a Smart Deal for Pfizer?
January 29, 2022
From Motley Fool
What's Next For Novavax Stock?
January 29, 2022
From Motley Fool
3 Things About BioNTech That Smart Investors Know
January 29, 2022
From Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
From Motley Fool
Why Novavax Stock Surged 14% on Friday
January 28, 2022
From Motley Fool
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
From Benzinga
This Clinical Respiratory Company Has Been Easing the Burden on the Healthcare System During the Pandemic — It's Looking to Continue to Do So Beyond
January 28, 2022
From Benzinga
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.